RP
Ravi Prakash Srivastava
About Ravi Prakash Srivastava
Data last updated:
Ravi Prakash Srivastava is a Director at Nix Pharma Private Limited (since 2016) and Director at Emeric Pharma Private Limited (since 2022). The companies operate in Trading and Chemicals. The 2 current companies with reported revenue have a combined latest revenue of ₹5.2 Lakh; the largest is Nix Pharma Private Limited at ₹3.4 Lakh (FY 2017).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Nix Pharma Private Limited U33111UP2011PTC048154 | Director | 16 Mar 2016 | 2011 | ₹3.4 Lakh (FY 2017) | Active |
| Emeric Pharma Private Limited U24290HR2022PTC100361 | Director | 05 Jan 2022 | 2022 | ₹1.8 Lakh (FY 2025) | Active |
Board colleagues of Ravi Prakash Srivastava
| Name | DIN | Company | Designation |
|---|---|---|---|
| Shiv Bachan Singh | 05114450 | Nix Pharma Private Limited | Director |
| Surya Prakash | 07207548 | Nix Pharma Private Limited , Emeric Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ravi Prakash Srivastava
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ravi Prakash Srivastava
Ravi Prakash Srivastava currently holds 2 directorships: Nix Pharma Private Limited (Director, since 16 Mar 2016, revenue ₹3.4 Lakh (FY 2017)); Emeric Pharma Private Limited (Director, since 05 Jan 2022, revenue ₹1.8 Lakh (FY 2025)).
Ravi Prakash Srivastava was first appointed on 16 Mar 2016 as Director at Nix Pharma Private Limited. The most recent appointment on record is 05 Jan 2022 at Emeric Pharma Private Limited.
The 2 current companies of Ravi Prakash Srivastava that report revenue have a combined latest revenue of ₹5.2 Lakh: Nix Pharma Private Limited ₹3.4 Lakh (FY 2017); Emeric Pharma Private Limited ₹1.8 Lakh (FY 2025).
The current boards of Ravi Prakash Srivastava's companies include Shiv Bachan Singh (Nix Pharma Private Limited), Surya Prakash (Nix Pharma Private Limited).